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Received 18 August 2006; received in revised form 26 January 2007; accepted 29 January 2007; Available online 19 March 2007AbstractObjective: Assessment of postoperative quality of life in patients over 80 years after cardiac surgery including coronary artery bypass grafting
(CABG), aortic valve replacement (AVR) and combined procedures. Methods: Quality of life of n = 136 patients over 80 years at operation
(82.3  2.1 years), undergoing isolated CABG in 61 patients (45%), isolated AVR in 34 patients (25%) and a combination of CABG and AVR in 41
patients (30%) between January 1999 and December 2003 was reviewed. Preoperatively 66.2% presented in NYHA-class III/IV or CCS-class III/IV.
Mean ejection fraction (EF) was 59.5%  14.0 (range 25—90%). Quality of life assessment was performed via a Seattle Angina Questionnaire.
Follow-up was 100% complete for a total of 890 days (69—1853 days). Results: Five-year survival was 70% for the CABG group, 75% for the AVR
group and 65% for the CABG/AVR group. Quality of life was remarkable in all of the three groups after surgery. Overall 97 patients (81%)were not or
little disabled in their daily activity. One hundred and twelve patients (93%) were free or considerably less symptomatic. Seventy-eight patients or
65% reported to be very satisfied with their current quality of life and 112 patients (93%) felt very reassured to have continuous full access to
medical treatment despite of their advanced age. Conclusions: A remarkable quality of life and important improvement in the functional status
after cardiac surgery in patients over 80 paired with a satisfactory medium-term survival justify early intervention for heart disease in this age
group. Therefore, referral practice for patients over 80 years for heart surgery should be handled liberally.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Life expectancy has increased during recent decades
leading to an older growing population. In 1982, life
expectancy at birth for the overall population in Switzerland,
UK and USA was 76.3 years, 75.7 years and 75.5 years,
respectively. Ten years later, life expectancy has raised to
79.9 years for Switzerland, 77.9 years for UK and >77 years
for USA. By 2022, life expectancy will reach 82.0 years for
Switzerland, 80.8 years for UK and 80.2 for USA. An 80-year-
old Swiss male or female will live another 6.6 or 7.8 years,
respectively. Sixteen percent of the Western European
population, 13% in USA and 15% in Switzerland, compared
to 7% of the world population, is over 65 years of age. Five
percent of the Swiss population is aged 80 years and over, and
this age group continues to rise. It is estimated that the* Corresponding author. Address: Service de Chirurgie Cardiovasculaire,
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persons, at least 80 years of age, by 2050 [1].
Considering that heart diseases are the leading cause of
death in the industrialised nations and the prevalence of
coronary artery disease (CAD) is 18% in the United States, the
amount of patients seeking treatment will further increase.
Despite maximum medical therapy many patients of this age
group remain severely symptomatic of their cardiovascular
disease. Cardiovascular diseases are functionally limiting
more than 25% of the population aged 80 years and above [2].
Continuous advances in operative techniques, myocardial
protection and perioperative care have led to a steady
decline in operative mortality, and cardiac surgery can be
performed safely in patients of 80 years and older with good
mid-term results.
Quality of life (QoL) is becoming an increasingly important
aspect of assessing the outcome of any therapeutic inter-
vention, as well as a personal perception of his or her health,
physical well-being and mental state. Elkinton in 1966 [3]
described quality of life as ‘not just the absence of death but
life with the vibrant quality that was associate with the
vigour of youth’.Surgery. Published by Elsevier B.V. All rights reserved.
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2.1. Patient population
From a total of 161 octogenarians with consecutive heart
operations between January 1999 and December 2003 at a
single centre, all patients with either isolated coronary
artery bypass grafting (CABG), isolated aortic valve
replacement (AVR) or combined CABG/AVR were selected
(n = 136).
Data were extracted from retrospective review of
patients’ records. Information on quality of life of the 120
surviving patients and causes of deaths were obtained via
telephone interviews during a 2-month period by the same
investigator. The surviving patient himself was questioned in
the first line; relatives, patient’s general practitioners or
cardiologists and hospital autopsy records served to acquire
additional information.
The postoperative quality of life assessment is based on a
modified Seattle Angina Questionnaire and is 100% complete.
Mean follow-up was 890 days (maximum 1853 days, minimum
69 days).
2.2. Statistical analysis
Data were analysed with GraphPad PrismW (Version 3.02).
Data are presented as absolute numbers, mean  standard
deviation or percentages where appropriate. Long-term
survival was analysed using the Kaplan-Meier method.
2.3. Preoperative patients’ characteristics
The mean age of the 136 patients at operation was
82.3  2.1 years, ranging from 80 to 91 years. More than 13%
of the patients were 85 years or older. Eighty (59%) weremale
patients. Two-third presented with symptoms of NYHA-class
III or IV, respectively, CCS-class III or more. Body mass index
was 25.5  3.8 kg/m2. The preoperative variables are
summarised in Table 1.Table 1
Preoperative patient characteristics
Variables No. of patients (%)
All (n = 136) CABG (
Males 80 (59) 39 (64)
Age 82.3  2.1 82.0 
NYHA or CCS  III 90 (66) 43 (70)
Hypertension 83 (61) 38 (62)
Dyslipidemia 70 (51) 33 (54)
Pos. family history 34 (25) 14 (23)
NIDDM/IDDM 14 (10) 6 (10)
/2 (1.5) /2 (3
Creatinine  120 mmol/l 26 (19) 10 (16)
COPD 21 (15) 7 (11)
Tobacco abuse 33 (24) 23 (38)
PAD 19 (14) 10 (16)
Atrial fibrillation 26 (19) 7 (11)
Previous MI 35 (26) 27 (44)
Anticoagulation 14 (10) 8 (13)
Abbreviations: BMI, body mass index; CAD, coronary artery disease; CCS, Canadian Ca
infarction; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependen
Heart Association; PAD, peripheral arterial disease.2.3.1. Isolated coronary artery bypass grafting (n = 61
patients)
Unstable angina pectoris was the most common symp-
tom. Forty-two patients (69%) had a CCS of III or more.
Twenty-seven patients (44%) had a history of myocardial
infarction, in 11 patients less than 14 days before and in 16
patients more than 2 weeks before surgery. The left
ventricular ejection fraction (LVEF) was 59  13% and only
five patients (8.2%) presented with a LVEF of equal to or less
than 35%.
In 53 patients (87%) three-vessel and in 7 patients (11%)
two-vessel disease was present. Left main stem disease was
diagnosed in 25 patients (41%).
Quintuple CABG was performed in 7 patients (11%),
quadruple in 25 patients (41%), triple in 23 patients (38%),
whereas two-vessel revascularisation was performed six
times (10%). In 47 patients (77%) a left internal mammary
artery (LIMA) was harvested and 47 patients (77%) got one
or more arterial conduits. Eight (13%) radial arteries were
harvested and implanted. The operation time was
168  40 min and the bypass time was 77  29 min. Mean
aortic cross-clamp time was 46  18 min. Nine patients
(15%) needed inotropic support during weaning from
cardiopulmonary bypass (CPB) and one patient (1.6%)
required support via an intra-aortic balloon pump
(IABP).
2.3.2. Aortic valve replacement (n = 34 patients)
Twenty-one operated patients (62%) were in NHYA  III
and LVEF was 60.4  14%.
Severe aortic stenosis was the leading pathology in all 34
patients (100%). In 16 patients (47%) concomitant aortic
insufficiency grade I or II was noted. Nineteen (29%) patients
showed slight to moderate mitral valve insufficiency.
Stented bioprosthesis was implanted in 25 patients (74%),
stentless in 1 patient (3%) and a mechanical valve in 8
patients (24%). Mean cardiopulmonary bypass time was
76  28 min and mean aortic cross-clamp time was
53  14 min. Overall operation time was 152  37 min.n = 61) AVR (n = 34) CABG/AVR (n = 41)
15 (44) 26 (63)
1.8 82.6  2.0 82.5  2.6
21 (62) 26 (63)
15 (44) 30 (73)
14 (41) 23 (56)
6 (18) 14 (34)
3 (9) 5 (13)
.3) 0 0
7 (21) 9 (22)
7 (21) 7 (17)
4 (12) 6 (15)
4 (12) 5 (12)
10 (29) 9 (22)
2 (6) 6 (15)
5 (15) 1 (2.4)
rdiovascular Society; COPD, chronic obstructive airway disease; MI, myocardial
t diabetes mellitus; LVEF, left ventricular ejection fraction; NYHA, New York
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patients (29%), but none of the patients required IABP
support.
2.3.3. Coronary artery bypass grafting in combination
with aortic valve replacement (n = 41 patients)
Six patients (15%) had left main disease, 10 patients (24%)
presented with triple-vessel and 35 patients (87%) had either
double- or single-vessel CAD. Twenty (48%) patients had
single, 14 patients (34%) double and 11 patients (27%) triple
or more vessel revascularisation. Thirteen (31%) LIMA’s and
three (7.3%) radial arteries were harvested.
Stented bioprosthesis was implanted in 34 patients (83%),
stentless bioprosthesis in 1 patient (2.4%) and a mechanical
valve in 13 patients (31%). Mean cardiopulmonary bypass
time for combined AVR and CABG was 90  35 min and mean
aortic cross-clamp time 62  19 min. Overall operative time
was 169  41 min.
Nineteen (46%) patients required inotropic drugs for CPB
weaning, but IABP was never necessary in the perioperative
phase.3. Results
3.1. Early results
In Table 2 early complications (<30 days) are listed in
relation to the type of surgery.
The most frequent postoperative complications in all
groups were arrhythmias with atrial fibrillation in 29 patients
(21%). Permanent pacemaker became necessary in two
patients only (1.5%).
Four patients (3.0%) suffered perioperative myocardial
infarction after combined AVR/CABG but none required IABP
support in this group. Twenty-seven patients (20%) needed
inotropic drugs to wean from CPB and in 21 patients (15%)Table 2
Early complications (<30 days) in relation to the type of surgery and additionally a
Variables No. of patients (%)
All (n = 136)
Inotropic drug support required 27 (19.9)
IABP 1 (0.7)
ICU (days) 2.7  1.6
Prolonged ventilation (>24 h) 8 (5.9)
Duration of inotropes (h) 13.5  29.0
Number of intraoperative EC 1.5  2.0
Number of postoperative EC 1.0  5.1
Transient neurological impairment 3 (2.2)
Permanent neurological impairment 5 (3.7)
Myocardial infarction 4 (2.9)
Temporary dialysis 3 (2.2)
Antibiotic treatment (>48 h) 26 (19.1)
Deep sternal infections needing reoperation 2 (1.5%)
Reoperation for bleeding 6 (4.4%)
Atrial fibrillation 29 (21.3%)
Permanent pacemaker 2 (1.5%)
Hospital stay mean time (days) 14.2  10.1
Number of drugs at discharge 5
Abbreviations: EC, erythrocyte concentrate; IABP, intra-aortic balloon pump; ICU, iinotropes had to be continued for more than 24 h. Prolonged
mechanical ventilation (>2 days) was necessary in eight
patients (5.9%). The average length of stay in the intensive
care unit (ICU) was 2.7  1.6 days and five patients (3.7%)
stayed more than 1 week. Temporary dialysis was required in
two patients (1.5%), but in both the renal function recovered
completely. Eight patients (5.9%) underwent re-intervention:
in six patients (4.4%) for persistent bleeding and in two
patients (1.5%) because of deep sternal wound infection.
Five patients (3.7%) suffered from permanent neurologi-
cal impairment and three patients (2.2%) recovered fully
from a transient neurological impairment.
Hospital stay was 14.2  10.1 days including six patients
(4.4%) with a stay longer than 25 days (range 5—110).
3.2. Mortality (cumulative survival in brackets)
In-hospital death occurred in six patients (4.4%). One
month after surgery 130 patients (95%) were alive. Survival at
1, 3 and 5 years was 93%, 90% and 73%, respectively. Highest
mid-term survival rate was recorded in the isolated AVR with
31 patients (75%) alive. In contrast, combined operations
with CABG/AVR showed the lowest 5-year survival with 35
patients alive (65%). The CABG group survival positioned
itself between AVR and CABG/AVR groups with 54 patients
alive, corresponding to a cumulative 5-year survival of 70%
(see Fig. 1).
Causes of the 16 deaths over 5 years were mostly of non-
cardiac origin. Fatal pneumonia caused death in five patients
(31.3%). In two patients (12.5%) cerebrovascular accidents,
in three patients (18.8%) septicaemia, in one patient (6.3%)
mesenterial infarction, in one patient (6.3%) cerebral
haemorrhage and in one female patient (6.3%) euthanasia
led to death. In five patients (31.3%) a cardiac cause has been
found to be at the origin of death. Table 3 shows a comparison
of intervention-linked cumulative survival in octogenarians
after cardiac surgery.ssessed postoperative variables
CABG (n = 61) AVR (n = 34) CABG/AVR (n = 41)
9 (14.8) 9 (26.4) 9 (22.0)
1 (1.6) 0 0
2.8  1.5 2.6  1.2 2.7  2.1
4 (6.6) 3 (8.8) 3 (7.3)
8.3  22.3 17.6  33.0 0.75  1.4
1.4  1.8 1.8  2.2 1.5  2.0
1.4  7.4 0.9  2.0 0.5  1.2
1 (1.6) 0 2 (4.9)
4 (6.6) 1 (2.9) 0
0 0 4 (9.8)
1 (1.6) 1 (2.9) 1 (2.4)
5 (8.2%) 11 (32.4%) 10 (24.4)
0 2 (5.9%) 0
2 (3.3%) 2 (5.9%) 2 (4.8)
8 (13.2%) 10 (29.4%) 11 (26.8)
0 2 (5.9%) 0
14.1  13.5 13.8  5.9 14.8  6.2
5 5 5
ntensive care unit.
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Fig. 1. Kaplan-Meyer survival curves, comparing CABG, AVR and combined
procedures in patients over 80 years of age. Unit on the time axis is expressed
in days and unit on the survival axis is expressed in percentage.
Fig. 2. Percentage and absolute numbers of patients having answered ques-
tions 1 and 2 with no or little limitations in their daily activities.
Fig. 3. Percentage and absolute numbers of patients having answered question
3 with much less or less angina or dyspnoea and question 4 with angina or
dyspnoea less than once a week or never in the last 4 weeks.3.3. Mid-term results
3.3.1. Quality of life
Mean follow-up length was 890 days (range 69—1853).
Information was collected by telephone interviews.
One hundred and thirty patients left the hospital and at
follow-up 120 patients were alive. A validated Seattle Angina
Questionnaire including two additional questions regarding
dyspnoea was used to assess the quality of life (see Fig. 4a).
This 11-item multiple-choice instrument examines mobility
and activity, cardiac symptoms perception, disease percep-
tion, treatment satisfaction as well as emotional well-being
and enjoyment of life. In terms of also assessing valve
pathologies, dyspnoea as an additional symptom was added
to the questions regarding chest pain.
Quality of life improved considerably after cardiac
surgery. Overall 97 patients (81%) were not or little disabled
in their daily activities (see Fig. 2). Physical exercise was not
or little limited in 84 patients (70%). Symptoms decreased
post-cardiac surgery in 112 patients (93%), only 2 patients
(1.7%) felt worse than before operation and 6 patients (5%)
described unchanged symptoms (see Fig. 3). Eighty-six
patients (72%) were free of angina or dyspnoea, while eight
patients (6.6%) remained moderately to severely sympto-
matic. In the CABG group 42 patients (77.7%) did not have to
take nitroglycerin anymore. Overall 93 patients (77%) were
very satisfied and another 21 patients (17.4%) were satisfied
by the previous treatment. Only six patients (5%) did not feel
satisfied to take their prescribed medication. Furthermore,
112 patients (93.4%) were very reassured to have continuous
full access to medical treatments (see Fig. 4a).
Interference of cardiac disease with daily enjoyment of
life was described by only 9 patients (7.5%) while 111 patientsTable 3
Comparison of intervention-linked cumulative survival in octogenarians after cardia
Operation 30-day survival 1-year
All operations (n = 136) 95%  1.7 (7) 93% 
Isolated CABG (n = 61) 95%  2.7 (3) 93% 
Isolated AVR (n = 34) 97%  2.8 (1) 94% 
AVR and CABG (n = 41) 92%  4.0 (3) 92% 
In parentheses: cumulative absolute numbers of occurred death within every surviv(92.5%) had no reduction in their quality of life. Sixty-nine
patients (58%) were very optimistic to conserve their present
activity of life. Thirty-three patients (27.7%) did think about
recurrence of their heart disease from time to time, but only
17 patients (14.2%) were anxious more frequently to have a
heart attack or to die suddenly (Fig. 4b). In contrast, 30
patients (45%) undergoing aortic valve replacement, with or
without concomitant CABG, worried at least once a day of
dying versus 6 patients (11.1%) after isolated coronary artery
bypass surgery.
And finally, 116 patients (97%) at follow-up lived in their
own homes and preserved a high degree of self-care.4. Discussion
Since themid-1980s the peri- and postoperative survival in
octogenarians, after cardiac surgery, has steadily increased
to become highly acceptable nowadays [4]. Patients 80 years
and older represent a very distinct population from younger
cardiac patients [5]. Measurement of morbidity andmortality
provides only a small amount of information about thec surgery
survival 3-year survival 5-year survival
2.0 (9) 90%  2.1 (12) 73%  7.9 (16)
3.2 (4) 87%  5.3 (6) 70%  16.1 (7)
4.3 (2) 94%  4.3 (2) 75%  17.1 (3)
4.0 (3) 88%  5.3 (4) 65%  15.2 (6)
al interval.
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Fig. 4. (a) Percentage and absolute numbers of patients having answered
questions 7 and 8 being satisfied or very satisfied with their treatment. (b)
Percentage and absolute numbers of patients having answered questions 9 and
10, little interfered or not interfered, and satisfied or very satisfied about their
emotional well-being, and question 8 being satisfied or very satisfied with their
treatment as well as question 11 with rarely or never worrying about a heart
attack or sudden death event.patients’ postoperative physical, functional, emotional and
mental well-being.
Little is known about the postoperative symptom
perception in patients 80 years and older after cardiac
surgery. This study analyses the postoperative quality of life
in 120 consecutive octogenarians post-CABG, AVR or a
combination of both procedures. Mean follow-up was about
2.5 years and none of the surviving patients was lost at
follow-up. Information on quality of life was obtained from
close family members in the three patients with permanent
neurological impairment. No one refused to answer the
questionnaire. The quality of life of 54 patients after CABC
surgery, of 31 patients after AVR and 35 patients after
combined procedures was compared.
The initial assessment was based on the two main cardiac
functional symptoms: chest pain and dyspnoea. As older
patients are known to have advanced symptoms at presenta-
tion for surgery, NYHA class III and IV are more common
findings in octogenarians as they are in younger patients.
Alexander et al. [4] described NYHA class III to IV heart failure
being present in 16.6% compared to 9.8% in patients younger
than 80 years. Fruitman et al. [5] have also shown a
significant higher presence of NYHA IV in octogenarians.
Questions 1—5 of the Seattle Angina Questionnaire all
address either one or both symptoms. In CABG patients,
unstable angina pectoris was the presenting symptom with
more than two-third of the patients being in a CCS III. Near-
equal distribution was found for dyspnoea in patients
undergoing AVR with 62% being in NYHA  III. In the
combined CABG/AVR group the dyspnoea was the leading
symptom (see Table 1).The gender difference is decreasing with age progression.
Forty-one percent of patients were women opposed to 20—
30% described in younger population [4,6]. We did not
identify either trend for higher female or male in-hospital
mortality as described by other studies. Therefore, female
gender may be a weaker risk factor in elderly compared to
younger women.
The higher difference of pre- and postoperative symptoms
in this older patient subgroup is a further argument for the
benefit of early operative treatment in patients over 80 years
of age.
In 42% left main disease was present and CAD showed to be
more extensive in older patients at the time of surgery. In
contrast, LVEF did not differ from values in younger
collectives, and preoperative COPD or diabetes mellitus
was less likely to be found in octogenarians.
Compared to the literature [7] we used the left thoracic
artery more often (78%) for revascularisation of the LAD
territory. In our opinion the principle of the thoracic artery as
the graft of choice in CABG is valid in patients 80 years of age
as well.
Peripheral vascular disease wasmore commonly present in
CABG patients (17%) compared to patients undergoing AVR
with or without concomitant CABG (12%).
Three years after surgery, 124 patients (90%) were alive
and 120 patients (73%) 5 years after their operation (see
Table 3). These survival rates are comparable or slightly
higher than the ones described in other studies [4,6—9] and
show good early- and mid-term postoperative results,
justifying not withholding cardiac surgery from the increasing
elderly and very old population.
However, longevity is not the primary goal in patients over
80; therefore, good operative outcomes imply not only safety
and survival but also the gain of comfort in daily life. The
marked improvement of the NYHA functional class as well as
improvement of the CCS class we found (72% free of angina or
dyspnoea) has been reported previously [5,10,13]. Never-
theless, only marginal attention had been paid in most
studies to the improvement of emotional well-being,
treatment satisfaction and disease perception. The results
of the present study demonstrate a remarkable quality of life
and an important improvement in the patients’ functional
status after cardiac surgery in octogenarians.
Activity and mobility improved in ischaemic and valvular
disease with nearly 80% of the patients feeling no or only
little limitation in their daily activity (see Fig. 2). The
improvement in exercise tolerance is less homogenously
distributed, reporting 80% of CABG patients being virtually
free of limitation and only 59% of the patients in the
combined procedures group. This difference in exercise
tolerance is reflected again in the patient symptom
perception. Ninety-eight percent of the CABG patients
compared to 85% of CABG and AVR patients felt important
improvement of their angina or dyspnoea compared to their
preoperative clinical condition. The vast majority (93%) of all
the octogenarians felt much better after surgery (see Fig. 3).
Towards all types of operations, more than 90% of the
patients were at least satisfied or very satisfied with the
overall treatment of their heart disease. And it is noteworthy
that nearly 100% of the CABG patients as well as 91% of the
AVR or CABG and AVR patients felt pleased to have access to
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Fig. 4a). Over 95% of the patients at follow-up lived in their
own homes and enjoyed a high degree of autonomy. Similar
results have been found by Fruitman et al. [5], Heijmeriks
et al. [11], Rumsfeld et al. [12], Kumar et al. [13] and Yun
et al. [14].
Looking at an economical scale hospital costs have been
reported to be 20—27% higher in the older population [15].
Avery et al. attributed the increase of total direct hospital
cost in octogenarians to a more severe risk profile and to
longer consecutive ICU and hospital stay [6]. However,
emphasis on early extubation and timely aggressive mobi-
lisation after surgery also in this elderly patient population
has successfully decreased the overall intubation time and
length of stay in ICU to 2.8 days (see Table 2). This is between
the previously reported 6.8 days [4], or 5.1 days [8] and the
1.7—1.1 days of Dalrymple-Hay et al. [16]. Prolonged
ventilation (>24 h) was required in only 8.7%, summarising
all cardiac procedures in our study population. Our hospital
stay of 14.5 days is in the range of previous publications [10].
The excellent postoperative recovery and quality of life gave
back the potential of self-care and reduced consecutive
disease-associated costs compared to medical treatments
with repeated hospitalisation for repetitive heart failure
[17].
In summary, selected patients of 80 years and older after
cardiac surgery show a remarkable quality of life and a
considerable increase in their emotional well-being (see
Fig. 4b), as well as a important increase in their functional
status with a satisfactory medium-term 5-year survival (see
Fig. 1) at a reasonably low risk. The stunning recovery from
being a bedridden patient to a self-caring patient is a further
very important advantage after cardiac surgery in this
challenging age group. Therefore, in selected octogenarians,Table 4
Questionnaire used for quality of life assessment via telephone interview
No. Question (Q)/Answer options (A)
1 Q: How limited are you in your daily activit
A: Severely limited/moderately limited/lim
2 Q: How limited are you moving upstairs or
A: Severely limited/moderately limited/lim
3 Q: Compare your angina or dyspnoea today
A: Lot more/somewhat more/unchanged/le
4 Q: Over the past 4 weeks, on average, how
A: Four times or more a day/1—3 times a d
5 Q: Over the past 4 weeks, on average, how
A: Four times or more a day/1—3 times day
6 Q: How bothersome is it for you to take yo
A: Very/moderately/little/not at all/no dru
7 Q: How satisfied are you that everything po
A: Not satisfied/somewhat satisfied/satisfie
8 Q: How satisfied are you with the overall tr
A: Very dissatisfied/somewhat dissatisfied/l
9 Q: Over the past 4 weeks, how much has yo
A: Strongly interfered/somewhat interfered
10 Q: If you had to spend the rest of your life
A: Very dissatisfied/somewhat dissatisfied/l
11
(a) Q: (a) How often do you worry that you ma
A: Can’t stop/often/from time to time/rar
(b) Q: (b) Where do you live?
A: At home/with my family/with friends/at
Translated from German.early operative treatment should not be withheld, and
adoption of an early referral practice might further increase
the postoperative patients benefits.
4.1. Limitations
The present study has several limitations. The use of a
modified Seattle Angina Questionnaire instead of the SF-36
questionnaire [18,19] was motivated by the increased age,
the specific disease and treatment characteristics of the
analysed patient population. The SF-36 is a multipurpose,
short-form health survey with 36 questions. It yields an 8-
scale profile of functional health and well-being scores, as
well as psychometrically based physical and mental health
summary. It is known to be a generic measure, as opposed to
one that targets a specific age, disease or treatment group.
The Seattle Angina Questionnaire [20,21] as opposed to the
SF-36 is a shorter 11-item questionnaire measuring five
dimensions including physical limitation, anginal stability,
anginal frequency, treatment satisfaction and disease
perception targeting a specific disease and treatment group.
The lower number of questions and the nature of the
questions were found to be more adequate to the very old
patient population. All questions investigating angina-
related outcomes had to be supplemented with the symptom
of dyspnoea in order to address aortic valve disease as well
(see Table 4). This modification is by itself not validated but
does not interfere with the angina assessment and provide a
simple tool to measure valve related QoL perception.
Further, the 136 patients represent a selective subgroup
of the entire population. Coronary artery disease as well as
valve pathologies might follow a different disease progres-
sion in these older patients and certainly show a delayed
onset. A further limitation is the relatively small sample size,ies inside your flat/house?
ited/little limited/not limited
walk up a little hill?
ited/little limited/not limited
and before the operation?
ss/much less
many times have you had angina or dyspnoea?
ay/3 or more times a week/less than once a week/never in the last 4 weeks
many times have you taken nitroglycerin?
/3 or more times a week/less than once a week/never in the last 4 weeks
ur pills as prescribed?
gs prescribed
ssible is being done to treat your heart?
d/very satisfied
eatment of your heart disease?
ittle dissatisfied/satisfied/very satisfied
ur angina or dyspnoea interfered with your enjoyment of life?
/little interfered/not interfered
with your actual discomfort, how would you feel about this?
ittle dissatisfied/satisfied/very satisfied
y have a heart attack or die suddenly?
ely/never
a nursery home
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outcome. However, the number of patients in the present
series was similar to previous studies assessing cardiac
surgery in octogenarians. Although we extracted retro-
spective data, no patient was lost in the follow-up.
This study reports postoperative results of a single centre,
which may introduce institutional bias. Despite these
possible limitations, postoperative survival and overall
quality of life in patients 80 years and older were very good.
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